Rejoyn app cleared for treating depression by FDA
According to a press release by the US Food and Drug Administration (FDA), the agency has cleared the depression treatment app Rejoyn for marketing by Otsuka America Pharmaceutical, Inc. and Click Therapeutics, Inc. The companies’ own press release describes the app as “the first prescription…